Urinary incontinence management organized by clinical phenotype — treatment selection, surgical technique, and device options for stress, urgency, and mixed presentations across male and female patients. The treatment ladder for each phenotype is anchored on the AUA / SUFU 2024 OAB and 2023 SUI guidelines and the 6th International Consultation on Incontinence (ICI) framework, with phenotype-specific severity tiers driving operative selection: mild SUI permits sling-first approaches, while moderate-to-severe SUI in the male favors AUS based on the MASTER RCT secondary outcomes.

The three searchable databases below are organized by phenotype rather than technique — each links from a clinical entry-point (female SUI, male SUI, OAB / UUI) to the full procedural toolkit, then cross-links to the technique deep-dives on individual sling, neuromodulation, behavioral, and device pages. Conservative therapy (pelvic-floor PT, behavioral) is the universal first rung; surgical and neuromodulatory escalation are guided by phenotype, severity, and patient comorbidity.

• Female Stress Urinary IncontinencePelvic floor PT, bulking agents, mid-urethral slings, autologous fascial sling, Burch colposuspension, AUS
• Male Stress Urinary IncontinencePelvic floor PT, penile clamp, male urethral slings, adjustable continence devices, artificial urinary sphincter
• OAB & Urgency Urinary IncontinenceBehavioral therapy, anticholinergics, beta-3 agonists, intradetrusor Botox, sacral neuromodulation, PTNS, bladder augmentation